Although the blockage of PD-1 and/or CTLA-4 can promote the activation of T cells and exert an effective anti-tumor function, the exuberant activation of self-reactive T cells with the resultant autoimmunity is presumed to be an irAE (8). The gene discussed is RPL17; the disease is Autoimmunity.